24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit 2020 earlier this month. As part of the ‘new normal’, the meeting this year was virtual, and content was available on demand. This allowed multiple members of the Patient Engagement Team to attend and gain insights on the latest in the patient engagement field….
Alan Thomas is a patient advocate for rare diseases, and ataxia in particular. He is known as the ‘rare disease warrior’ and, as a patient with a life-limiting rare disease, he can convey the patient engagement message from his point of view on all issues regarding the wellbeing of patients.
After finishing my undergraduate degree in biomedical sciences, I was eager to harness the skills I had developed and transfer them to a new environment. This led me to apply for an internship at Oxford PharmaGenesis.
Throughout the COVID-19 pandemic, Oxford PharmaGenesis has been in the fortunate position of being able to continue to recruit HealthScience experts for a variety of roles across our global locations. We asked a few of our new colleagues to share their experiences of joining us remotely.
Throughout the COVID-19 pandemic, our colleagues have volunteered their time in many different and inspiring ways. Read more about the experiences of two of our colleagues.
This year saw the first virtual edition of the Communiqué Awards, with Oxford PharmaGenesis strongly represented among a multitude of faces online, celebrating excellence in international healthcare communications. While the COVID-19 pandemic precluded the razzmatazz of the usual black-tie dinner and awards ceremony in London, the virtual event nevertheless continued the Communiqué mission to recognize…
